Fibrinolysis

Plasminogen & α2-antiplasmin

BIOPHEN™ FVIII:C CE-IVD Chromogenic assay for quantitative determination of FVIII:C in human plasma or therapeutic concentrate. 221402 R1,R2,R3: 2x2.5mL; R4: 4x25mL
221406 R1,R2,R3: 2x6mL; R4: 4x25mL
Factor VIII:C Deficient Plasma CE-IVD Immunodepleted plasma deficient in FVIII. DP040A 1x1mL
DP040K 6x1mL

PAI-1 and tPA: Activity and Antigen

LIAPHEN™ vWF:Ag CE-IVD Immunoturbidimetric as say for in vitro quantitative determination of von Willebrand Factor Antigen (vWF: Ag) on human citrated plas ma. Liquid reagent, ready to use. 120206 R1: 4 x 5 mL; R2: 4 x 6 mL
ZYMUTEST™ vWF CE-IVD ELISA method for quantitative determination of von Willebrand Factor (vWF) Antigen. RK030A 96 tests
ZYMUTEST™ vWF:CBA CE-IVD ELISA method for quantitative determination of collagen binding activity (CBA) of von Willebrand Factor. RK038A 96 tests
Ristocetin CE-IVD Ristocetin (7.5 mg per vial) AG004K 3 x 0.5 mL
Lyophilized platelets CE-IVD Platelets for determination of vWF activity through Ristocetin Co-Factor assay. AG006A 1 x 5 mL
AG006K 3 x 5 mL

TAFI

HEMOCLOT™ Factor VIIa CE-IVD Clotting method for quantitative determination of Activated FVII. CK092K R1,R2: 3x2mL
BIOPHEN™ Factor VIIa CE-IVD Chromogenic assay for quantitative determination of Activated FVII. 221312 R1,R3: 2x4mL; R2: 2x2mL; R4: 2x25mL